Table 9 ER+, PR+ and HER2 subgroup rates for the 2006 audit according to location of laboratory and rates of unsatisfactory performance in one or more technical exercises.
| Location | Location of labs | ER positive (%) | PR positive (%) | HER2 positive (%) | ER technical unsatisfactory (%) | PR technical unsatisfactory (%) | HER2 technical unsatisfactory (%) | |
|---|---|---|---|---|---|---|---|---|
| Australia | NSW | 73 | 66 | 13 | 51 | 40 | 71 | |
| Vic | 80 | 62 | 16 | 56 | 47 | 43 | ||
| Qld | 82 | 65 | 12 | 40 | 34 | 58 | ||
| SA | 78 | 70 | 19 | 26 | 17 | 37 | ||
| WA | 79 | 65 | 15 | 57 | 35 | 38 | ||
| Tas | 66 | 51 | 20 | 50 | 33 | 50 | ||
| NZ | 77 | 67 | 13 | 46 | 39 | 55 | ||
| International | 57 | 50 | 33 | 50 | 28 | 41 | ||
| Total laboratories | 67 | Average | 74 | 62 | 18 | 47 | 34 | 49 |
| SD | 8 | 7 | 7 | 10 | 9 | 12 |
ER, oestrogen receptor; PR, progesterone receptor.